Uptrend on the daily chart: above its 50- and 200-day averages · 50-day below the 200-day · SuperTrend up since Oct 9 · above the Ichimoku cloud · RSI 71 (overbought) · MACD above its signal
None of the 29 investors followed here reported a position in AMBU-B.CO in their latest filing.
From each investor's quarterly 13F filing with the SEC: positions at the quarter's end, reported up to 45 days later. All investors
No member of Congress has disclosed a AMBU-B.CO trade since 2025.
From House and Senate STOCK Act reports. Members disclose trades, not holdings, as value ranges up to 45 days later, so amounts are estimates and “last move” is a hint at who still holds it, not a position. All recent congress trades
No insider transactions reported for AMBU-B.CO.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -3.3 | -6.6 | -14.0 | -7.8 | 6.9 | -9.5 | 18.6 | -1.7 | -3.1 | 12.0 | −12.2% | ||
| 2025 | 29.6 | -2.4 | -10.3 | -0.2 | -13.9 | -1.9 | -3.1 | -0.1 | -3.8 | 8.7 | -13.3 | 0.8 | −15.4% |
| 2024 | 9.2 | 5.0 | -5.8 | -0.9 | 16.7 | 2.0 | 4.4 | -8.6 | 2.5 | -3.2 | -12.5 | -6.3 | −1.1% |
| 2023 | 5.6 | 9.9 | -0.6 | 4.3 | 1.8 | 2.3 | -10.4 | -16.5 | -11.5 | -5.9 | 34.0 | 13.0 | +18.2% |
| 2022 | -19.5 | -11.8 | -18.6 | -5.6 | 0.5 | -27.4 | 19.7 | -9.5 | -11.0 | 27.0 | 5.1 | 0.3 | −48.6% |
| 2021 | 10.4 | -1.8 | 4.4 | 16.3 | -34.5 | 6.2 | -3.8 | -14.2 | -4.6 | -3.5 | 1.4 | -6.9 | −34.3% |
| 2020 | 10.6 | 24.0 | 7.9 | 29.3 | 4.8 | -6.9 | 5.5 | -16.6 | -1.9 | 7.6 | 7.9 | 25.9 | +135.6% |
| 2019 | 10.2 | -10.9 | 14.5 | 8.4 | -45.6 | 2.4 | -7.1 | 17.4 | -2.2 | -7.3 | 11.4 | -4.7 | −28.7% |
| 2018 | 15.7 | -8.2 | 15.5 | 5.3 | 33.3 | 12.4 | 16.4 | -4.0 | -35.9 | -11.0 | -4.1 | 18.9 | +40.8% |
| 2017 | 3.9 | -4.0 | 6.2 | 12.0 | 32.1 | -5.4 | -2.5 | 9.7 | 8.5 | 20.9 | -11.2 | 6.3 | +96.1% |
| 2016 | 1.7 | 10.3 | -1.3 | -3.4 | 21.7 | 1.3 | 2.5 | 17.3 | 7.2 | -1.4 | -22.6 | 4.4 | +35.3% |
| 2015 | -6.0 | -2.5 | 17.9 | 9.0 | 13.4 | -12.3 | 6.3 | 11.1 | -12.4 | 1.9 | 12.0 | 1.7 | +40.6% |
| 2014 | 7.1 | 2.5 | 8.6 | 1.8 | -2.1 | 12.8 | 1.5 | 1.5 | 3.9 | -1.2 | 3.7 | 36.9 | +101.4% |
| 2013 | -1.3 | 13.4 | 13.5 | -1.0 | -6.8 | -0.8 | 9.2 | -3.7 | 15.2 | 10.5 | 6.5 | 12.3 | +86.2% |
| 2012 | 9.7 | -6.3 | 1.0 | -2.3 | -1.4 | -1.4 | -7.0 | 6.8 | 5.0 | 3.7 | -2.3 | 6.0 | +10.4% |
| 2011 | 3.1 | -11.1 | 12.5 | -13.9 | 4.5 | -8.4 | 3.6 | -1.1 | -1.4 | -10.5 | 7.3 | 8.3 | −10.6% |
| 2010 | 8.3 | 7.7 | 4.8 | 9.1 | -4.5 | 7.3 | -1.7 | -7.6 | 1.1 | 2.2 | 13.4 | 2.5 | +49.1% |
| 2009 | 14.0 | 11.0 | -5.2 | 6.7 | -2.3 | 10.6 | 3.2 | -1.5 | 15.2 | -5.5 | 2.4 | 1.4 | +58.8% |
| 2008 | 8.0 | 8.7 | -2.5 | 3.2 | 4.3 | -14.1 | -12.3 | 26.6 | -9.9 | -6.8 | 2.9 | -2.9 | −1.4% |
| 2007 | 2.8 | -9.8 | 0.5 | 2.5 | 2.9 | -1.9 | -8.6 | 1.0 | -10.3 | -1.1 | -9.9 | -11.0 | −36.7% |
Ambu A/S, together with its subsidiaries, researches, develops, manufactures, markets, and sells medical technology solutions in North America, Europe, and internationally. The company offers endoscopy products, including bronchoscopes, video laryngoscopes, rhinolaryngoscopes, duodenoscopes, gastroscopes, cystoscopes, ureteroscopes, and displaying and processing units; neurology products, such as EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products; and cardiology products comprising ECG electrodes. It also provides airway management and anaesthesia products, which include double and single lumen tubes, endobronchial blockers, laryngeal and face masks, breathing bags, and resuscitators. In addition, the company offers emergency care and training products, such as extrication collars and ALS and BLS training manikins, as well as mobile workstations, IOMs, and patient monitoring and diagnostics devices. Further, the company manufactures video capture solutions for OEMs in medical and defense imaging applications. Ambu A/S was founded in 1937 and is headquartered in Ballerup, Denmark.
Buy / hold / sell counts
No recent headlines.